Home › Atrial Fibrillation › NCT06075628

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Long-Term Outcomes of Left Atrial Appendage Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Subjects must be at least 18 years of age.
* Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at our institution from January 2019 till June 2022

Exclusion Criteria:

* No definite exclusion criteria are defined for the study as all patients with Watchman-FLX or Amplatzer Amulet will be included in the study.

About the study

This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.

What is being tested

• Left Atrial Appendage Occlusion (other)

Sponsor: Kansas City Heart Rhythm Research Foundation · Participants: 100 · Started: Jul 24, 2023

Contact the study team

• Donita Atkins · Phone: 816-651-1969

Official record on ClinicalTrials.gov — NCT06075628

Locations in the U.S.

Conditions

• Atrial Fibrillation
• Ischemic Stroke

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.